** Shares of cannabis companies rise premarket, extending a
recent surge on hopes of U.S. legalization of marijuana
** The U.S. Department of Health and Human Services (HHS) on
Wednesday recommended easing restrictions on marijuana following
a review request from the Biden Administration last year
** HHS is recommending reclassifying marijuana to say it has
a moderate-to-low potential for dependence and a lower abuse
potential, which would put it in a class with ketamine and
testosterone
** Reclassifying marijuana as less harmful than drugs like
heroin would be a first step toward wider legalization, a move
backed by a majority of Americans
** U.S.-listed shares of Canadian cannabis firms Cronos
Group CRON.TO CRON.O , OrganiGram Holdings OGI.TO OGI.O ,
Aurora Cannabis ACB.TO ACB.O and Canopy Growth WEED.TO
CGC.O up between 1% and 11.5% premarket
** AdvisorShares Pure US Cannabis ETF MSOS.N up 2.8% after
surging 36% in the past two sessions
** MSOS down 3.4% YTD
(Reporting by Sruthi Shankar)
((sruthi.shankar@thomsonreuters.com;))